ThursdayJan 26, 2023 10:52 am

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Year-End Webcast Review

Flora Growth (NASDAQ: FLGC), a leading outdoor grower, manufacturer and distributor of cannabis products and brands worldwide, has scheduled a webcast to provide an overview of the company’s operational milestones achieved in 2022. The year-end review is slated for Jan. 30, 2023, and will begin at 4:30 p.m. ET. The webinar, which will be prerecorded, will feature Flora Growth chair and CEO Luis Merchan, who will discuss the company’s 2022 operational performance; Merchan will also talk about the company’s 2023 revenue guidance. Those who attend the event will receive a recording of the webcast after it is concluded; a recording…

Continue Reading

MondayJan 23, 2023 1:26 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pharmaceutical Expert as New Strategic Advisor

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has a new strategic advisor. The company announced that Julian Gangolli, the former president of GW Pharmaceuticals USA, has joined Lexaria as a strategic advisor. During his time at GW Pharmaceuticals, Gangolli managed US Food and Drug Administration approval of Epidiolex(R), the only pure cannabidiol (“CBD”) drug ever approved by the agency; he also oversaw the commercialization of the drug in the United States, which ultimately led to Jazz Pharmaceuticals acquiring GW Pharmaceuticals in a $7.2 billion transaction. In addition to his work at GW Pharmaceuticals, Gangolli served as North…

Continue Reading

MondayJan 23, 2023 12:59 pm

TinyGemsBreaks – QSAM Biosciences Inc. (QSAM) to Present at Emerging Growth Conference

QSAM Biosciences (OTCQB: QSAM) is developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam(R)), for the treatment of bone cancer and related diseases and conditions. The company today announced that it has been invited to present at the Emerging Growth Conference at 10:15 a.m. ET on Wednesday, Jan. 25, 2023. Leading QSAM’s presentation will be the company’s CEO Douglas Baum and other executive officers, who may subsequently open the floor for questions. Interested parties should visit https://ibn.fm/P2xIR to register to attend the conference and receive any updates. An archived webcast will be made available on EmergingGrowth.com and on the Emerging Growth YouTube…

Continue Reading

MondayJan 23, 2023 10:15 am

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Unveils Streamlined, Automated Carrier Onboarding Process

Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning, offers a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region, has announced a new, automated and effortless carrier onboarding process. The new process, states the company, makes it even easier qualified carriers to sign up and move loads with Fr8App. The announcement noted that qualified carriers who sign up on the Fr8App platform, can approved and unlock all the platform options in only minutes; users simply follow step-by-step instructions that are provided. The new streamlined process…

Continue Reading

FridayJan 20, 2023 10:41 am

TinyGemsBreaks — Cepton Inc. (NASDAQ: CPTN) Completed $100M Koito Manufacturing Investment

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has closed its previously announced $100 million investment with Koito Manufacturing Co. Ltd.; Koito is a long-term automotive Tier 1 partner and current CPTN shareholder. The transaction closed on Jan. 19, 2023, and was in the form of convertible preferred stock. Cepton’s stockholders approved the move at a special meeting held on Jan. 11, 2023. The investment is convertible into shares of Cepton’s common stock at an initial conversion price of $2.585 per share; the conversion date begins on the first anniversary of the issue date. “We’re happy…

Continue Reading

ThursdayJan 19, 2023 11:13 am

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Secures Contract Renewals for Multiple Key Clients

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and emergency systems, announced that seven key clients have renewed their contracts for another year. The renewal agreements include a hospital, hotel, bank, commercial property developer, mass media company, and two residential communities, representing clients from a variety of industries. Knightscope’s innovative solutions have enabled these clients to reduce crime rates and improve security operations at their respective facilities, and their renewals affirm the trust they place in the company to continue delivering on their mission to protect the places people live, work, study and visit. “Ongoing renewals from our…

Continue Reading

WednesdayJan 18, 2023 10:35 am

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Promising Results from Kernel Flow(R) Feasibility Study

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced key highlights from the completed feasibility study conducted by its partner HI, LLC dba Kernel (“Kernel”). The study was designed to evaluate Kernel’s Flow(R) wearable technology to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics. “The results from the feasibility study are very promising and provide further insights into the potential of this cutting-edge wearable technology to quantify neural activity and changes in brain biomarkers during the administration of psychedelics. The possibility of using this technology to develop a predictive tool to aid…

Continue Reading

TuesdayJan 17, 2023 11:11 am

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Provides Strategic Update in Annual Shareholder Letter

Lexaria Bioscience (NASDAQ: LEXX) CEO Chris Bunka has released an annual letter to shareholders. The detailed letter talks about company highlights throughout the year, including the fact that, despite challenges such as global supply chain disruptions and threatening inflation, “Lexaria continues to navigate well and is focused on those things it can control such as applied R&D designed to entice others to work with us commercially. . . . [The company] has not terminated any staff and in fact our in-house team as well as our external consultant head-count has never been higher, in order to conduct and [analyze] an…

Continue Reading

ThursdayJan 12, 2023 1:10 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin to Be Evaluated in Investigator-Initiated Phase 1b/2 Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced an investigator-initiated phase 1b /2 trial evaluating the company’s novel anthracycline, Berubicin. The study, titled “Evaluation of the safety and efficacy of Berubicin in the treatment of central nervous system lymphomas,” will be conducted at the Pomeranian Medical University (“PUM”) in Szczecin, Poland. “Based on the data seen to date, Berubicin has continued to demonstrate an overall safety profile more favorable than other known anthracyclines and we remain encouraged by its potential.…

Continue Reading

ThursdayJan 12, 2023 12:46 pm

TinyGemsBreaks – Vision Energy Corp. (VENG) Issues Update on Recent Market Activity

Vision Energy (OTC: VENG) (the “Company”) today issued statements regarding recent removal from the OTCQB Market. On Dec. 6, 2022, Vision Energy was informed by the OTC Markets Group Inc. of certain promotional material that encouraged investors to purchase or trade the Company’s common stock. On Jan. 10, 2022, the Company was informed that, due to the ongoing promotional campaign, it would be moved from the OTCQB Market to the Pink Market effective Jan. 11, 2023. As detailed in the update, Vision Energy is and continues to be committed to compliance with OTC Markets’ policy on stock promotion and the…

Continue Reading

Contact us: (512) 354-7000